The pharmacological evidence of the chang-yan-ning formula in the treatment of colitis
Ulcerative colitis (UC) is a subtype of inflammatory bowel disease (IBD) and occurs mainly in the colon. The etiology of UC is rather complex and involves various pathological factors, including genetic susceptibility, dietary intakes, environment, and microbiota. In China, the Chang-Yan-Ning (CYN)...
Main Authors: | Wei Yu, Yijia Zhang, Cai Kang, Yang Zheng, Xincheng Liu, Zhenghao Liang, Jing Yan |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2022-10-01
|
Series: | Frontiers in Pharmacology |
Subjects: | |
Online Access: | https://www.frontiersin.org/articles/10.3389/fphar.2022.1029088/full |
Similar Items
-
Berberine promotes M2 macrophage polarisation through the IL-4-STAT6 signalling pathway in ulcerative colitis treatment
by: Kai Xiong, et al.
Published: (2023-03-01) -
Yan (Kedah) [peta]
Published: (1985) -
Roles of macrophages on ulcerative colitis and colitis-associated colorectal cancer
by: Maorun Zhang, et al.
Published: (2023-03-01) -
Naringin Exhibited Therapeutic Effects against DSS-Induced Mice Ulcerative Colitis in Intestinal Barrier–Dependent Manner
by: Ruige Cao, et al.
Published: (2021-10-01) -
The pulmonary biopharmaceutics and anti-inflammatory effects after intratracheal and intravenous administration of Re-Du-Ning injection
by: Wei Jia-Xing, et al.
Published: (2023-04-01)